Investors

Webcast ImageWebcast - Replay
OraSure Technologies, Inc. at the UBS 2016 Global Healthcare Conference
05/23/16 at 10:30 a.m. ET
OraSure Technologies, Inc. at the UBS 2016 Global Healthcare Conference
Monday, May 23, 2016 10:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities.
More>>
Featured Reports
Fact Sheet - PDF Fact Sheet
2015 Annual Report on Form 10-K - PDF 2015 Annual Report on Form 10-K
OSUR (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$7.51
Change (%) Stock is Up 0.17 (2.32%)
Volume1,087,872
Data as of 05/27/16 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
05/10/16OraSure Technologies to Hold Virtual Annual Meeting of Stockholders
BETHLEHEM, Pa., May 10, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), announced that its 2016 Annual Meeting of Stockholders will be a completely virtual meeting, conducted as a live webcast beginning at 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time) on Tuesday, May 17, 2016. In order to access the meeting, interested parties may go to www.virtualshareholdermeeting.com/OSUR2016 five (5) minutes prior to the start of the meeting to log in. Stockholders must enter the c... 
Printer Friendly Version
05/04/16OraSure Announces 2016 First Quarter Financial Results
BETHLEHEM, Pa., May 04, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the first quarter ended March 31, 2016. Financial Highlights Consolidated net revenues for the first quarter of 2016 were $29.1 million, a 7% increase from the first quarter of 2015.   Net domestic revenues from sales of the Company’s OraQuick® rapid HCV test wer... 
Printer Friendly Version
05/03/16OraSure Technologies to Present at the UBS 2016 Global Healthcare Conference
BETHLEHEM, Pa., May 03, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the UBS 2016 Global Healthcare Conference in New York.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak May 23, 2016, at approximately 10:30 AM Eastern Time (7:30 AM Pacific T... 
Printer Friendly Version
04/15/16OraSure Technologies Appoints New Chief Science Officer
Michael Reed, Ph.D. named Senior Vice President of Research and Development and Chief Science Officer BETHLEHEM, Pa., April 15, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) announced today that Michael Reed, Ph.D. has been named as the Company’s Senior Vice President of Research and Development and Chief Science Officer. He will begin working at the Company on April 18, 2016. Dr. Reed brings to OraSure Technologies more than 20 years of experience in life sciences and ... 
Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources



Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet